Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Operating expenses:        
Research and development $ 2,377 $ 7,795 $ 6,865 $ 13,769
General and administrative 2,386 2,499 4,481 4,983
Loss from operations (4,763) (10,294) (11,346) (18,752)
Interest income 171 109 350 185
Interest expense (119) (485) (1,085) (961)
Net loss attributed to Common Stockholders $ (4,711) $ (10,670) $ (12,081) $ (19,528)
Basic and diluted net loss per common share $ (0.13) $ (0.38) $ (0.34) $ (0.73)
Weighted average common shares outstanding—basic and diluted 36,005,294 28,095,522 35,953,234 26,646,993